An exploratory study on the effect of continuous intake of test foods on the immune system. -a randomized, placebo-controlled, double-blind, parallel-group comparison trial- - An exploratory study on the effect of continuous intake of test foods on the immune system.

IMEQRD Co., Ltd0 sites24 target enrollmentDecember 27, 2022

Overview

Phase: 未知
Intervention: Not specified
Conditions: Not specified
Sponsor: IMEQRD Co., Ltd
Enrollment: 24
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

December 27, 2022

End Date

April 22, 2022

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

IMEQRD Co., Ltd

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\.Individuals who have mouth dryness, or hypersalivation. 2\.Individuals who are currently undergoing treatment for any disease with medical drugs or traditional Chinese medicines. However, medications used as needed will be allowed to join the trial. 3\.Individuals who are managed by medical doctors for diet therapy and exercise therapy. 4\.Individuals who have severe diseases or a history of severe diseases. 5\.Individuals who have allergic dermatitis, allergic rhinitis, bronchial asthma, or chronic bronchitis. 6\.Individuals who have been taking yogurts or beverages, which include Lactic acid bacteria and/or Bifidobacterium. 7\.Individuals who have currently been taking commercially available drugs, quasi\-drug products, and foods or supplements with functional claims. 8\.Individuals who have a drug allergy, or a food allergy. 9\.Individuals who work in shift, night shift, and marked irregular work in shift. 10\.Individuals who are planning extremely change their lifestyle (such as diet, sleep, or exercise) during the trial period. 11\.Individuals who drink more than 60 g alcohol/day. 12\.Individuals who have been vaccinated to protect against infectious disease one month before the screening period. Also, individuals who are planning vaccination during the trial period. 13\.Individuals who are planning travel to foreign countries during the trial period. 14\.Individuals who joined other clinical trials from 1 month before obtaining informed consent in this trial, or individuals who have currently been joined other clinical trials. Also, individuals who are planning to join other clinical trials. 15\.Individuals who donated blood more than 200 mL within one month before, or more than 400 mL within three months before the screening period. 16\.Individuals who cannot discontinue taking any alcoholic drinks two days before the date of visit. 17\.Individuals who are unsuitable for this trial, that judged by the principal investigator.